scholarly journals Flixweed vs. Polyethylene Glycol in the Treatment of Childhood Functional Constipation: A Randomized Clinical Trial

2015 ◽  
Vol 25 (3) ◽  
Author(s):  
Majid Nimrouzi ◽  
Omid Sadeghpour ◽  
Mohammad Hadi Imanieh ◽  
Mohammadreza Shams Ardekani ◽  
Alireza Salehi ◽  
...  
2021 ◽  
Author(s):  
Heidar Safarpour ◽  
Mohammad Hadi Imanieh ◽  
naser honar ◽  
sajad hekmati ◽  
Naeimehossadat Asmarian

Abstract BackgroundThis study aimed to compare different regimens of Polyethylene Glycol (PEG, single dose vs. divided dose) in the treatment of functional constipation among children aged 4-15 years.Materials and MethodsThis double-blind randomized clinical trial was conducted on the children (4-15 years old) with functional constipation who were visited in an outpatient pediatric clinic affiliated to Shiraz University of Medical Sciences between February and July 2021. Among the120 eligible patients, 80 ones who met the inclusion criteria were recruited. The patients were divided into two parallel groups; the children who received single-dose PEG (group A) and those who received PEG in divided doses (group B). The study was performed during 12 weeks and follow-up visits were scheduled at 1, 3, 6, and 12 weeks after enrollment. The outcomes were measured using the Bristol Stool Form Scale (BSFS).ResultsThe study was performed on 78 cases including 45 boys (57.7%) and 33 girls (42.3%) with the mean age of 5.52±1.79 years. After 12 weeks, a significant difference was observed between groups A and B regarding the mean of BSFS (4.94±0.52 vs. 4.50±0.88, p=0.008). However, no significant difference was observed between the two groups regarding the number of defecation times during the study. The detected complications included mild abdominal pain in eight children in group A (5.3%), fecal incontinency in six children in group B (3.8%), and painful defecation in six children in group B (3.8%).ConclusionThis study confirmed that the administration of the single dose (0.4 g/kg) of PEG early in the morning was more effective, well tolerated, and accompanied by fewer complications compared to the divided dose.


2016 ◽  
Vol 18 (7) ◽  
Author(s):  
Mohammad Reza Esmaeilidooki ◽  
Seyyed Ali Mozaffarpur ◽  
Mohaddese Mirzapour ◽  
Hoda Shirafkan ◽  
Mohammad Kamalinejad ◽  
...  

2020 ◽  
Vol 4 (2) ◽  
pp. 54
Author(s):  
Lourianne Nascimento Cavalcante ◽  
Adriana Ribas ◽  
Alexandre Pithon Lins ◽  
Luciana Rodrigues Leal da Silva ◽  
Flora Maria Lorenzo Fortes ◽  
...  

Author(s):  
Seyyed Ali Mozaffarpur ◽  
Mohsen Naseri ◽  
Mohammad Reza Esmaeilidooki ◽  
Mohammad Kamalinejad ◽  
Ali Bijani

2020 ◽  
Vol 22 (3) ◽  
pp. 135-140
Author(s):  
Karamali Kasiri ◽  
Morteza Sedehi ◽  
Sheida Mortazavi

Background and aims: Constipation is one of the most common issues in pediatrics. The aim of this study was to compare the effect of polyethylene glycol and the simultaneous administration of polyethylene glycol along with probiotics in the treatment of chronic functional constipation. Materials and Methods: In this randomized double-blind clinical trial, 150 children with chronic functional constipation referred to Imam Ali Clinic affiliated with Shahrekord University of Medical Sciences from 2017 to 2018 were included. The first group (A) consumed 1 g/ kg of body weight per day of water-soluble polyethylene glycol powder and the second group (B) consumed a probiotic powder and 1 g/kg of body weight of the water-soluble polyethylene glycol powder daily. In weeks 0, 1, and 2, questionnaires were filled out by the parents of the children and the data were analyzed. Results: The results showed that there was no significant difference in any of the variables between groups A and B (P=0.07) including the frequency of fecal excretion in week 1 (77% and 71%) and week 2 (4% and 5.4%) and stool consistency in week 1 (4% and 6.7%) and week 2 (86.7% and 92%). Moreover, there was no significant difference between groups A and B in any of the variables frequency of painful excretion in week 1 (74% and 73%, respectively) and week 2 (5.3% and 4%, respectively), frequency of abdominal pain in week 1 (61.3% and 49.3%, respectively) and week 2 (4% and 5.3%, respectively), and the frequency of fecal incontinence in week 1 (22.77% and 18.7%, respectively) and week 2 (6.7% and 1.3%) (P>0.05, respectively). Conclusion: Our results indicated that the administration of probiotic supplement (Lactobacillus Rhamnosus, Lactobacillus acidophilus, Lactobacillous Bulgaricus) has no effect on the improvement of symptoms in children with chronic constipation.


2016 ◽  
Vol 83 (5) ◽  
pp. AB226 ◽  
Author(s):  
Hiroshi Kanie ◽  
Issei Kojima ◽  
Hiromichi Araki ◽  
Atsunori Kusakabe ◽  
Shuya Shimizu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document